FDA Considers Tanezumab Application for Chronic OA Pain
FDA Approves Meloxicam Injection & OTC Diclofenac Sodium Topical Gel for Pain Management
A Public Health Approach to Arthritis
Increasing Opioid Dose May Not Help Chronic Pain
FDA Advisory Committees Reject Oxycodegol (NKTR-181) Application
Cannabinoids Show Potential in Pain Management
Tanezumab’s Phase 3 Results for OA
IV Meloxicam Stalls at FDA; Plus Health Canada Approves Risankizumab for Plaque Psoriasis
Chronic Opioid Use in Rheumatoid Arthritis: Prevalence & Predictors
- 1
- 2
- 3
- …
- 13
- Next Page »